Sector portfolio · VC firm · Switzerland

Novartis' Biotech portfolio

Novartis has backed 51 Biotech startups in rounds we track, $5.4B between them, shown by the stage each has reached. The best-funded is Freenome.

51startups backed
4stages
$5.4Braised between them
Stage not reportedbiggest stage

Novartis's whole portfolioNovartis's profile

Stage not reported

14

Series A

14

Series B

13

Series C and later

10

Segment by segment

Stage not reported

14 startups · $1.5B raised

  1. FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
  2. Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
  3. C4 TherapeuticsC4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.United States$125M
  4. LightshipLightship is an all-electric RV manufacturer, designer, and a producer of an aerodynamic, battery-powered trailer for the electric age.United States$77M
  5. AAnokionSwitzerland$75M
  6. Alladapt ImmunotherapeuticsAlladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.United States$50M
  7. IInflazomeIreland$46M
  8. Credence MedSystemsCredence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely.United States$41M

Series A

14 startups · $884M raised

  1. GentiBioGentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapiesUnited States$157M
  2. Caribou BiosciencesCaribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.United States$139M
  3. RhygazeRhyGaze is a biotechnology company based in Basel, Switzerland, and Philadelphia, Pennsylvania, founded in 2024.Switzerland$86M
  4. IFM TherapeuticsIFM Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, focused on developing innovative therapies for canUnited States$83M
  5. CTCoDa TherapeuticsUnited States$78M
  6. Alesta TherapeuticsAlesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.Netherlands$67M
  7. Tagworks PharmaceuticalsTagworks Pharmaceuticals is a clinical-stage precision oncology company based in Nijmegen, Netherlands, with operations in Boston, U.S.Netherlands$65M
  8. AAkuousUnited States$50M

Series B

13 startups · $1.6B raised

  1. Intellia TherapeuticsIntellia Therapeutics is a genome editing company that develops curative gene-editing treatments.United States$485M
  2. Aktis OncologyAktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.United States$175M
  3. Mediar TherapeuticsMediar Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2018-2019.United States$161M
  4. Semma TherapeuticsSemma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.United States$158M
  5. Homology MedicinesHomology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.United States$144M
  6. Bicycle TherapeuticsBicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.United Kingdom$110M
  7. CitryllCitryll is a biotechnology company based in Oss, Netherlands, founded in 2015.Netherlands$90M
  8. ArtiosArtios Pharma Limited is a privately held biotechnology company based in Cambridge, United Kingdom, at the Babraham Research Campus.United Kingdom$83M

Series C and later

10 startups · $1.4B raised

  1. Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
  2. Pear TherapeuticsPear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engageUnited States$239M
  3. Science 37Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.United States$236M
  4. Rani TherapeuticsRani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.United States$168M
  5. Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
  6. ONL TherapeuticsONL Therapeutics is a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, founded in 2011.United States$67M
  7. CotaCOTA Healthcare is a healthcare technology company focused on oncology real-world data (RWD) and advanced analytics.United States$62M
  8. Orionis BiosciencesOrionis Biosciences is a clinical-stage life sciences company based in Waltham, Massachusetts, with a research facility in Ghent, Belgium.United States$59M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Novartis as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapNovartis portfolio map68 startups · $7.0BInvestments abroadNovartis' investments in the United States44 startups · $5.8BCo-investorsWho invests with Novartis42 co-investorsSector portfolioLakestar's AI portfolio26 startups · $4.6BSector portfolioLakestar's Fintech portfolio20 startups · $7.3BSector portfolioRedalpine's AI portfolio16 startups · $701M

Raising from investors like Novartis?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps